Neurobiology Research Unit  
 
 santini

Martin Andreas Santini

MSc, PhD student


Scientific interests

Schizophrenia is a highly disabling chronic disease with devastating consequences for affected individuals and their families. The underlying etiology and pathogenesis of schizophrenia is still only partly understood. However, antipsychotic drugs blocks a number of G-protein coupled receptors of which the serotonin 2A (5-HT2A) receptors in the prefrontal cortex (PFC) seems to be important for their clinical effect. Recent research indicates that the 5-HT2A receptor in the PFC interacts with other neurotransmitter systems, especially dopamine and glutamate. It is our hypothesis that schizophrenia is associated with an inbalance in these interactions. Thus, the main aim of my project is to study how 5-HT2A receptor neurotransmission and PFC-dependent behavior are affected by dopamine and glutamate. In different in vitro systems we will investigate how dopamine and glutamate affects 5-HT2A receptor functionality and gene expression. Furthermore, in vivo studies will be utilized to study whether the same interactions modulates PFC-mediated cognitive functions. 

Biography

2010 -   PhD Student, NRU and Cimbi 
2009 - 2009  Research assistant, NRU and Cimbi 
2009 MSc in Human Biology, University of Copenhagen 

Publications


Awards


Address

Neurobiology Research Unit (NRU) & Cimbi
Copenhagen University Hospital, Rigshospitalet
Blegdamsvej 9, DK-2100 Copenhagen, Denmark
Phone: +45 3545 6736 or +45 2656 7131
Fax: +45 3545 6713
E-mail: martin.santini#nru.dk